| 摘要 |
In its many embodiments, the present invention provides certain pyrazolo[1,5-a]pyrimidine compounds of Formula (I) which can have utility as inhibitors of cyclin dependent kinases (''CDKs'') as well as methods of preparing such compounds. The compounds can have potential utility for the treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs.
|
